Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

3.950 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AtaiBeckley Inc. - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
29 30 Next >
News headline image
atai Life Sciences Reports Third Quarter 2022 Financial Results and Business Update
From atai Life Sciences
Via GlobeNewswire
News headline image
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From November 8, 2022 ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14 
Via Benzinga
News headline image
The Psychedelic Drug Stocks Index Continued To Plummet Last Week ↗
In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD. 
Via Talk Markets
News headline image
Psyched: Brock Pierce Joins Psychedelic VC, Colorado's Psychedelics Legalization, Zappy Zapolin's Open Letter & More ↗
Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable' 
Via Benzinga
News headline image
Compass Pathways, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44 
Via Benzinga
News headline image
These Are The Top Companies And Most Influential People In The Psychedelics Space: Meet The Winners Of The Microdose Awards ↗
Which are the top companies and who are the most influential people in the psychedelics space? According to Microdose Psychedelic Insights, host of the Microdose Awards, these are the ones to watch. 
Via Benzinga
News headline image
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance ↗
(Part four of a four-part series) See previous stories in this series:  
Via Benzinga
News headline image
Women in Psychedelics Announces atai as Platinum Sponsors
From Women in Psychedelics Network
Via Business Wire
News headline image
EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable' ↗
Brock Pierce, the crypto billionaire, economist and philanthropist serving as chairman of the Bitcoin Foundation, has joined Jeremy Gardner’s psychedelics-focused venture fund Mystic Ventures as a... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From November 3, 2022 ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27 
Via Benzinga
News headline image
New Oral Film Tech Improving Cannabinoid Onset Seeks Patent Protection ↗
Pharmaceutical films leader IntelGenx Corp. (OTCQB: IGXT) filed a provisional patent application with the U.S. 
Via Benzinga
News headline image
Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S. ↗
Easily identified by its red cap covered with white dots and a white stem, the Amanita muscaria mushroom is probably the most famous and easily recognizable mushroom in the world. Popularized by Lewis... 
Via Benzinga
News headline image
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS: 
Via Benzinga
News headline image
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Why Shares of atai Life Sciences Climbed 14.58% on Tuesday ↗
The company specializes in developing psychedelics as therapies. 
Via The Motley Fool
News headline image
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads. 
Via Benzinga
News headline image
atai Life Sciences to Participate in November Investor Events & Healthcare Conferences
From atai Life Sciences
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗
Upgrades 
Via Benzinga
News headline image
atai Life Sciences to Announce Third Quarter 2022 Financial Results and Business Update
From atai Life Sciences
Via GlobeNewswire
News headline image
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo's Investment Fundamentals & Specificities ↗
(Part one of a four-part series) 
Via Benzinga
News headline image
A Sinister Reason May Be Behind Governors' Opposition To Cannabis Legalization ↗
As one Republican governor after another rejects President Biden’s suggestion to pardon simple cannabis possession convictions, one wonders what they're thinking. 
Via Benzinga
News headline image
October Recap: Major Psychedelic Drug Stocks Declined 9.9% ↗
In total, thePsychedelic Drug Stock Index went down 9.9% in September and is now down 64.7% YTD. 
Via Talk Markets
News headline image
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 3.00% at $0.87 
Via Benzinga
News headline image
Atai's Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon ↗
Clinical stage psychedelics company atai Life Sciences (NASDAQ: ATAI) and its majority-owned subsidiary Perception Neuroscience completed patient enrollment for their Phase 2a clinical trial assessing... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From October 26, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.39% at $0.18 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From October 25, 2022 ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.24% at $10.39 
Via Benzinga
News headline image
Canadian Company's New Version Of Chemo-Induced Pain Treatment Is On FDA Track ↗
Drug delivery company IntelGenx Corp. 
Via Benzinga
News headline image
atai Life Sciences Company, Perception Neuroscience, Completes Enrollment for Phase 2a Clinical Trial of PCN-101 (R-Ketamine) for Treatment-Resistant Depression
From atai Life Sciences
Via GlobeNewswire
News headline image
Cannabis Category Performances Ranged From +14.4% To -4.6% This Past Week ↗
The 5 categories in the cannabis sector perform quite differently week to week. Below is a summary of how each category performed last week, in descending order and since the end of September and since... 
Via Talk Markets
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.